[The progress in dermatomyositis (ProDerm) study : First phase III study on the use of intravenous immunoglobulins in dermatomyositis]
Z Rheumatol
.
2023 Oct;82(8):688-691.
doi: 10.1007/s00393-023-01376-9.
Epub 2023 Jun 2.
[Article in German]
Author
Jutta Bauhammer
1
Affiliation
1
Praxis für Rheumatologie, Tätigkeitsschwerpunkt Klinische Immunologie, Medical Center Baden-Baden, Beethovenstr. 2, 76530, Baden-Baden, Deutschland. j.bauhammer@rheuma-badenbaden.de.
PMID:
37268787
DOI:
10.1007/s00393-023-01376-9
No abstract available
Publication types
Clinical Trial, Phase III
MeSH terms
Dermatomyositis* / diagnosis
Dermatomyositis* / drug therapy
Humans
Immunoglobulins, Intravenous / therapeutic use
Polymyositis*
Substances
Immunoglobulins, Intravenous